Image 1
Dextroamphetamine Sulfate Capsule, Extended Release
Product Images NDC 45963-305
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Sulfate (NDC 45963-305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 10
This text provides the description and usage information for Dextroamphetamine Sulfate Extended-Release Capsules. It includes information on the medication's dosage, storage temperature, manufacturing details, and safety precautions for dispensing. The text also advises pharmacists to dispense the medication guide to patients and provides a website for printing additional guides. The serialization coding area and product lot number are displayed.*
Image 2
Image 3
Image 4
Image 5
Image 6
Image 7
Image 8
This medication is Dextroamphetamine Sulfate in extended-release capsules form. Each capsule contains 5 mg of the active ingredient and is designed to release an initial dose promptly, followed by a gradual release over a prolonged period of time. The medication guide should be dispensed to each patient by the pharmacist. The usual dosage should be determined based on the accompanying prescribing information. Safety closures should be used when dispensing this product unless otherwise directed. It should be stored in a tight, light-resistant container at room temperature between 20°C and 25°C. The manufacturer is Teva Pharmaceuticals. Serialization coding area and LOT/EXP number are also present. Print Medication Guides can be obtained from www.tevausa.com/medguides.*
Image 9
This is a medication for prescription use with the name Dextroamphetamine Sulfate Extended-Release Capsules. It comes in a bottle with 90 capsules to be dispensed by a pharmacist along with a Medication Guide for patients. The capsules contain 10 my of Dextroamphetamine Sulfate and are prepared to release an initial dose promptly and gradually release the remaining medication over a prolonged period. The normal dosage information is available in the prescribing information. It needs to be stored in a tightly closed, light-resistant container within 68° and 77°F. It is manufactured by Teva Pharmaceuticals and the details on lot number and expiration date are provided. There is a serialization coding area on the bottle. To know more, the Medication Guide can be accessed at www.tevausa.com/medguides.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
